Browse the evidence

Adopting MLCDs, particularly those with sufficient fiber content, can reduce the risk of cardiovascular diseases in patients suffering from dyslipidemia.

Practitioners may consider recommending MLCDs with sufficient fiber to patients with dyslipidemia to help reduce cardiovascular risks.

Soy isoflavones can significantly contribute to lowering metabolic risk and affect hormonal balance in women with PCOS.

Incorporating soy isoflavones may be beneficial for women with PCOS in managing metabolic and hormonal issues.

All patients had complete diabetes remission at 12 months, maintained at 24 months.

Laparoscopic sleeve gastrectomy can lead to significant diabetes remission in obese patients, which is important for treatment planning.

The intervention resulted in a significant improvement in fruit and vegetable consumption, increasing by 4% of daily energy intake.

Practitioners can focus on dietary interventions to improve fruit and vegetable intake among nurses.

The Mediterranean diet is advised for cardiovascular prevention in patients with familial hypercholesterolemia (FH).

Practitioners should consider recommending the Mediterranean diet to patients with FH.

Limiting dietary fat and saturated fatty acids is an advised strategy for managing familial hypercholesterolemia.

Practitioners should advise FH patients to limit dietary fat and saturated fatty acids.

Supplementation of phytosterols and fiber can be helpful in managing familial hypercholesterolemia.

Practitioners may consider recommending phytosterol and fiber supplements to FH patients.

Participants assigned to either the in-person or the remote lifestyle intervention were twice as likely as those assigned to the control group to have lost 5% or more of their initial body weight at 2 years.

Incorporating in-person or remote lifestyle interventions can significantly enhance weight loss outcomes in obese patients.

Weight loss at 2 years was similar in the groups that received in-person support (5.1 kg) and remote support (4.5 kg) and was significantly greater than the weight loss in the control group (0.8 kg).

Both in-person and remote support can lead to significant weight loss compared to standard care.

Whey protein shows greater rates of MPS compared to soy protein at equivalent doses.

Whey protein may be a better choice for promoting muscle protein synthesis in elderly individuals compared to soy.

Patients with obesity experienced a median weight change of -5% at 6 months and -4% at 18 months after the intervention.

Practitioners can expect significant weight loss in patients with obesity following a multicomponent lifestyle intervention.

Patients reported increased participation in physical activities by +1 day/week after the intervention.

Encouraging physical activity is essential in lifestyle interventions for obesity.

Carbohydrate-restricted diets (CRDs) significantly improved glycemic control, including glucose (SMD = -2.94 mg/dL), insulin (SMD = -8.19 pmol/L), and HOMA-IR (-0.54).

Practitioners may consider CRDs as an effective strategy for improving glycemic control in adults.

LCDs and MCDs showed the most consistent metabolic benefits, particularly with combined fat and protein replacements.

Practitioners should consider LCDs and MCDs with mixed macronutrient replacements for optimal metabolic health.

Weight-reducing anti-diabetic agents and anti-obesity medications can effectively address both obesity and type 2 diabetes mellitus (T2DM).

Practitioners should consider using these combined strategies for better management of patients with obesity and T2DM.

Utilizing a combination of weight-reducing anti-diabetic agents, anti-obesity medications, and surgical procedures can lead to better clinical outcomes in patients with obesity and T2DM.

Combining different treatment modalities may enhance patient outcomes in managing obesity and T2DM.

Nutritional counseling and remote monitoring led to a statistically significant reduction in the average consumption of products containing fats and salt among overweight and obese women.

Practitioners can implement nutritional counseling and remote monitoring to effectively reduce fat and salt intake in overweight and obese patients.

The intervention resulted in a decrease in body weight, body mass index, waist circumference, blood pressure, and lipid metabolism parameters.

Health professionals can expect improvements in key health metrics when implementing similar interventions.

Dietary correction over 6 months contributed to the reduction of risk factors for cardiovascular diseases.

Dietary interventions can be effective in reducing cardiovascular disease risk factors in overweight and obese populations.

Strength training in elderly overweight women exerts positive effects on upper and lower limb strength and also increases cognitive performance.

Incorporating strength training can enhance cognitive function in older women who are overweight.

Weight loss interventions can improve reproductive outcomes in women.

Implementing weight loss strategies may enhance fertility treatment success.

Treat weight-loss maintenance differently from weight loss.

Practitioners should emphasize different strategies for maintaining weight loss compared to initial weight loss efforts.

Low-fat diets are best for preventing weight regain.

Practitioners should recommend low-fat diets to clients aiming to maintain weight loss.

Substitution of LCSBs for sugar-sweetened beverages (SSBs) is associated with a reduction in body weight by −0.47 kg and risk of diabetes (RR, 0.94).

Replacing SSBs with LCSBs may aid in weight loss and reduce diabetes risk.